Clinical Trials Logo

Clinical Trial Summary

In this study, the investigators will monitor patients undergoing hemodialysis treatment with a non-invasive wearable PPG-based device. Measurements will include blood pressure, heart rate, oxygen saturation, stroke volume, cardiac output, cardiac index and systemic vascular resistance, among others. The aim is to diagnose intradialytic hypotension more rapidly than with current noninvasive methods and prevent related poor outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04680039
Study type Observational
Source Biobeat Technologies Ltd.
Contact
Status Completed
Phase
Start date January 15, 2021
Completion date March 15, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05297786 - Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease Phase 2
Active, not recruiting NCT02182089 - Measuring Cardiovascular Stress in Patients on Hemodialysis Study II